Novadiscovery
Lyon
About Novadiscovery
novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enabling scientists and biotech, pharma companies to predict drug efficacy and create the target combination.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $8.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2021)
- Website: novadiscovery.com
- Phone: 33463600506
Industries & Categories
Artificial Intelligence (AI), Biotechnology, CRM, Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/novadiscovery-41497 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.